Literature DB >> 33218980

Core Outcome Sets for Studies of Diabetes in Pregnancy: A Review.

Aoife M Egan1, Delia Bogdanet2, Linda Biesty3, Oratile Kgosidialwa2, Carmel McDonagh4, Christine O'Shea4, Paula M O'Shea2, Declan Devane3,5,6, Fidelma P Dunne.   

Abstract

Core Outcome Sets (COS) contain an agreed minimum set of outcomes to be measured and reported in all studies in a specific area, with the objective of standardizing outcome reporting. COS may minimize research waste by identifying outcomes important to key stakeholders, allowing for improved evidence synthesis, and facilitating translation of research findings to clinical practice. Over the past 5 years, there has been significant progress in developing COS relevant to studies of diabetes in pregnancy. This review summarizes work in this area, reviews the role of patient and public involvement in COS development, and suggests areas for future research.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2020        PMID: 33218980     DOI: 10.2337/dc20-1621

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  2 in total

1.  Resolving the Gestational Diabetes Diagnosis Conundrum: The Need for a Randomized Controlled Trial of Treatment.

Authors:  Rudolf W Bilous; Paul B Jacklin; Michael J Maresh; David A Sacks
Journal:  Diabetes Care       Date:  2021-04       Impact factor: 17.152

2.  A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study.

Authors:  O Kgosidialwa; D Bogdanet; A M Egan; P M O'Shea; C Newman; T P Griffin; C McDonagh; C O'Shea; L Carmody; S D Cooray; E Anastasiou; E Wender-Ozegowska; C Clarson; A Spadola; F Alvarado; E Noctor; E Dempsey; A Napoli; C Crowther; S Galjaard; M R Loeken; Mja Maresh; P Gillespie; H de Valk; A Agostini; L Biesty; D Devane; F Dunne
Journal:  BJOG       Date:  2021-08-03       Impact factor: 7.331

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.